Found 141 results
Filters: Author is de Leon, Mony J  [Clear All Filters]
2020
Waterhouse NN, Kothari PJ, Dooley M, Hu B, de Leon MJ, Babich J, Qu W.  2020.  Synthesis of [1-C]Butanol via a facile solid phase extraction protocol.. Appl Radiat Isot. 159:109078.
2019
Glodzik L, Rusinek H, Tsui W, Pirraglia E, Kim H-J, Deshpande A, Li Y, Storey P, Randall C, Chen J et al..  2019.  Different Relationship Between Systolic Blood Pressure and Cerebral Perfusion in Subjects With and Without Hypertension.. Hypertension. 73(1):197-205.
Fossati S, Cejudo JRamos, Debure L, Pirraglia E, Sone JYeong, Li Y, Chen J, Butler T, Zetterberg H, Blennow K et al..  2019.  Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease.. Alzheimers Dement (Amst). 11:483-492.
Butler T, Deshpande A, Harvey P, Li Y, Rusinek H, Pirraglia E, Osorio RS, Glodzik L, de Leon MJ, Madelin G et al..  2019.  Precisely-Measured Hydration Status Correlates with Hippocampal Volume in Healthy Older Adults.. Am J Geriatr Psychiatry. 27(6):653-654.
Kam K, Parekh A, Sharma RA, Andrade A, Lewin M, Castillo B, Bubu OM, Chua NJ, Miller MD, Mullins AE et al..  2019.  Sleep oscillation-specific associations with Alzheimer's disease CSF biomarkers: novel roles for sleep spindles and tau.. Mol Neurodegener. 14(1):10.
2018
Walters MJ, Sterling J, Quinn C, Ganzer C, Osorio RS, Andrews RD, Matthews DC, Vallabhajosula S, de Leon MJ, Isaacson RS et al..  2018.  Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area.. BMJ Open. 8(11):e023664.
Butler T, Harvey P, Deshpande A, Tanzi E, Li Y, Tsui W, Silver C, Fischer E, Wang X, Chen J et al..  2018.  Basal forebrain septal nuclei are enlarged in healthy subjects prior to the development of Alzheimer's disease.. Neurobiol Aging. 65:201-205.
Solesio ME, Peixoto PM, Debure L, Madamba SM, de Leon MJ, Wisniewski T, Pavlov EV, Fossati S.  2018.  Carbonic anhydrase inhibition selectively prevents amyloid β neurovascular mitochondrial toxicity.. Aging Cell. 17(4):e12787.
Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJelle, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L et al..  2018.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.. World J Biol Psychiatry. 19(4):244-328.
Illán-Gala I, Pegueroles J, Montal V, Vilaplana E, Carmona-Iragui M, Alcolea D, Dickerson BC, Sánchez-Valle R, de Leon MJ, Blesa R et al..  2018.  Challenges associated with biomarker-based classification systems for Alzheimer's disease.. Alzheimers Dement (Amst). 10:346-357.
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S, Isaacson RS et al..  2018.  Correction: Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.. PLoS One. 13(2):e0193314.
Mosconi L, Rahman A, Diaz I, Wu X, Scheyer O, Hristov HWebb, Vallabhajosula S, Isaacson RS, de Leon MJ, Brinton RDiaz.  2018.  Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study.. PLoS One. 13(12):e0207885.
Mosconi L, Walters M, Sterling J, Quinn C, McHugh P, Andrews RE, Matthews DC, Ganzer C, Osorio RS, Isaacson RS et al..  2018.  Lifestyle and vascular risk effects on MRI-based biomarkers of Alzheimer's disease: a cross-sectional study of middle-aged adults from the broader New York City area.. BMJ Open. 8(3):e019362.
Berti V, Walters M, Sterling J, Quinn CG, Logue M, Andrews R, Matthews DC, Osorio RS, Pupi A, Vallabhajosula S et al..  2018.  Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults.. Neurology. 90(20):e1789-e1798.
Snyder HM, Carare RO, DeKosky ST, de Leon MJ, Dykxhoorn D, Gan L, Gardner R, Hinds SR, Jaffee M, Lamb BT et al..  2018.  Military-related risk factors for dementia.. Alzheimers Dement. 14(12):1651-1662.
de Leon MJ, Pirraglia E, Osorio RS, Glodzik L, Saint-Louis L, Kim H-J, Fortea J, Fossati S, Laska E, Siegel C et al..  2018.  The nonlinear relationship between cerebrospinal fluid Aβ42 and tau in preclinical Alzheimer's disease.. PLoS One. 13(2):e0191240.
Sharma RA, Varga AW, Bubu OM, Pirraglia E, Kam K, Parekh A, Wohlleber M, Miller MD, Andrade A, Lewis C et al..  2018.  Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly. A Longitudinal Study.. Am J Respir Crit Care Med. 197(7):933-943.
Fortea J, Carmona-Iragui M, Benejam B, Fernández S, Videla L, Barroeta I, Alcolea D, Pegueroles J, Muñoz L, Belbin O et al..  2018.  Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.. Lancet Neurol. 17(10):860-869.
Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, Mintun MM, Lleó A, Molinuevo JLuis, Jagust WJ et al..  2018.  Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.. Alzheimers Dement. 14(7):913-924.
Chen J, Li Y, Pirraglia E, Okamura N, Rusinek H, de Leon MJ.  2018.  Quantitative evaluation of tau PET tracers F-THK5351 and F-AV-1451 in Alzheimer's disease with standardized uptake value peak-alignment (SUVP) normalization.. Eur J Nucl Med Mol Imaging. 45(9):1596-1604.
de Leon MJ, Li Y, Rusinek H.  2018.  Reply: Cerebrospinal Fluid, Hyposmia, and Dementia in Alzheimer Disease: Insights from Dynamic PET and a Hypothesis.. J Nucl Med. 59(4):718-719.
de Leon MJ, Blennow K.  2018.  Therapeutic potential for peripheral clearance of misfolded brain proteins.. Nat Rev Neurol. 14(11):637-638.
Ramos-Cejudo J, Wisniewski T, Marmar C, Zetterberg H, Blennow K, de Leon MJ, Fossati S.  2018.  Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link.. EBioMedicine. 28:21-30.
2017
de Leon MJ, Li Y, Okamura N, Tsui WH, Saint-Louis LA, Glodzik L, Osorio RS, Fortea J, Butler T, Pirraglia E et al..  2017.  Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET.. J Nucl Med. 58(9):1471-1476.
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S, Isaacson RS et al..  2017.  Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.. PLoS One. 12(10):e0185926.